1. Germeys, Christine, Vandoorne, Tijs, Davie, Kristofer, De Bock, Katrien, Van Den Bosch, Ludo. 2024. Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response. In Cell reports, 43, 114719. doi:10.1016/j.celrep.2024.114719. https://pubmed.ncbi.nlm.nih.gov/39255062/
2. Yang, Minghua, Chen, Pan, Liu, Jiao, Kang, Rui, Tang, Daolin. 2019. Clockophagy is a novel selective autophagy process favoring ferroptosis. In Science advances, 5, eaaw2238. doi:10.1126/sciadv.aaw2238. https://pubmed.ncbi.nlm.nih.gov/31355331/
3. Liu, Xijuan, Wang, Jun, Boyer, Joshua A, Baldwin, Albert S, Zhang, Qing. 2022. Histone H3 proline 16 hydroxylation regulates mammalian gene expression. In Nature genetics, 54, 1721-1735. doi:10.1038/s41588-022-01212-x. https://pubmed.ncbi.nlm.nih.gov/36347944/
4. Zhang, Jing, Wang, Chengyang, Chen, Xi, Liu, Xiaole Shirley, Zhang, Qing. 2015. EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer. In The EMBO journal, 34, 2953-70. doi:10.15252/embj.201591437. https://pubmed.ncbi.nlm.nih.gov/26492917/
5. Wang, Zheng, Yan, Meisi, Ye, Leiguang, Lu, Zhimin, Xu, Daqian. 2024. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation. In The EMBO journal, 43, 931-955. doi:10.1038/s44318-024-00051-2. https://pubmed.ncbi.nlm.nih.gov/38360997/
6. Zhang, Ruyang, Lai, Linjing, He, Jieyu, Chen, Feng, Christiani, David C. 2019. EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC. In Epigenetics, 14, 118-129. doi:10.1080/15592294.2019.1573066. https://pubmed.ncbi.nlm.nih.gov/30665327/
7. Qing, Liangliang, Li, Qingchao, Yang, Yongjin, You, Chengyu, Dong, Zhilong. 2024. Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer. In Molecular carcinogenesis, 63, 1303-1318. doi:10.1002/mc.23725. https://pubmed.ncbi.nlm.nih.gov/38634741/
智鼠故事 
